Trial intelligence / Profile preview

Adherence to Weekly vs Monthly Oral Vitamin D in Outpatients

NCT03141593Phase 4Completed

Sponsor
University Hospital Basel
Start
Oct 2017
Primary completion
Oct 2018
Modality
Orthosteric Ligands, Metabolically Activated Prodrugs
Countries
1
01

Overview

Phase 4, randomised, open-label trial of vitamin d in Vitamin D deficiency (VDD) (4 arms), sponsored by University Hospital Basel. Primary endpoint: Adherence to medication at 3 months. Started Oct 2017; status: completed.

02

Drugs

vitamin d
03

Conditions

Vitamin D deficiency (VDD)

Beyond the preview

Go deeper on NCT03141593.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03141593.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call